Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stephen J. Hartman"'
Publikováno v:
Advances in Surgery.
Autor:
Emily J. Schepers, Kathryn Glaser, Harrison M. Zwolshen, Stephen J. Hartman, Alexander J. Bondoc
Publikováno v:
Cancer Research.
Glypican-3 (GPC3) is a cell-surface glycoprotein that is frequently overexpressed in hepatocellular carcinoma. GPC3 undergoes extensive post-translational modification including cleavage and glycosylation. This review focuses on the structure and fun
Publikováno v:
Surgery.
Autor:
Tobin J. Ehrlich, Stephen J. Hartman, Brianna M. Paul, Manu Hegde, Vedang S. Uttarwar, Kushagra Mathur, Yu-Hsuan A. Chang, Carrie R. McDonald, Anny Reyes, Jerry J. Shih
Publikováno v:
Epilepsy Research. 149:30-36
Objective Individuals with temporal lobe epilepsy (TLE) often experience diminished quality of life (QoL). Although comorbid depression is one of the most recognized predictors of poor QoL in TLE, impairments in verbal memory (VM) and executive funct
Autor:
Romeo C. Ignacio, Nicholas C. Saenz, James M. Prieto, Karen Kling, Stephen W. Bickler, David A. Lazar, Stephen J. Hartman, John H. Naheedy, Timothy J. Fairbanks
Publikováno v:
Journal of pediatric surgery. 56(1)
The aims of this study were to identify ultrasound-based predictors of ovarian torsion in girls without an adnexal mass and establish a set of normal values for ovarian volume ratio (OVR).A retrospective review was performed of all premenarchal patie
Molecular Classification of Patients with Grade II/III Glioma Using Quantitative MRI Characteristics
Autor:
Anders M. Dale, Tyler M. Seibert, Jona A. Hattangadi-Gluth, Roshan Karunamuni, Nathan S. White, Nikdokht Farid, Naeim Bahrami, Carrie R. McDonald, David Piccioni, Yu-Hsuan A. Chang, Stephen J. Hartman, Rachel L. Delfanti
Publikováno v:
J Neurooncol
Journal of neuro-oncology, vol 139, iss 3
Bahrami, N; Hartman, SJ; Chang, Y-H; Delfanti, R; White, NS; Karunamuni, R; et al.(2018). Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics. JOURNAL OF NEURO-ONCOLOGY, 139(3), 633-642. doi: 10.1007/s11060-018-2908-3. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/2cc358xx
Journal of neuro-oncology, vol 139, iss 3
Bahrami, N; Hartman, SJ; Chang, Y-H; Delfanti, R; White, NS; Karunamuni, R; et al.(2018). Molecular classification of patients with grade II/III glioma using quantitative MRI characteristics. JOURNAL OF NEURO-ONCOLOGY, 139(3), 633-642. doi: 10.1007/s11060-018-2908-3. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/2cc358xx
BACKGROUND: Molecular markers of WHO grade II/III glioma are known to have important prognostic and predictive implications and may be associated with unique imaging phenotypes. The purpose of this study is to determine whether three clinically relev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca8e4278e73b7ceb13ecade01aefa1cf
https://europepmc.org/articles/PMC8120480/
https://europepmc.org/articles/PMC8120480/